# Viscofan agrees to acquire 85% stake in Shandong Haiaos Biotechnology

Viscofan Group has reached an agreement in principle to acquire up to 85% of China-based collagen-casing producer Shandong Haiaos Biotechnology through its Suzhou subsidiary. The deal is valued against a €133 million enterprise value, with Haiaos generating approximately €57.5 million in revenue and €16.5 million in EBITDA in 2025.

- Type: Acquisition
- Announced: 2026-11-06
- Where: Shandong, China, China
- Value: $143.0M (133.0M EUR)
- Status: announced
- Products: collagen casings
- Sectors: [Packaging](https://endata.com/sectors/packaging.md)

## Companies

- [Viscofan](https://endata.com/companies/12543.md) (acquirer)
- [Shandong Haiaos Biotechnology](https://endata.com/companies/95118.md) (target)

## Sources

- [tipranks.com](https://www.tipranks.com/news/company-announcements/viscofan-agrees-in-principle-to-acquire-majority-stake-in-haiaos), 2026-11-06: "The proposed acquisition, valued against a €133 million enterprise value, would combine Haiaos’ local capabilities with Viscofan’s expertise, expanding production capacity and strengthening its regional presence."
- [en.empresaexterior.com](https://en.empresaexterior.com/Viscofan-acquires-85%25-of-China%27s-Haiao%27s-for-113-million-to-accelerate-its-expansion-in-Asia/), 2026-11-07: "The combination of local capabilities of Haiaos with the technological, industrial and commercial experience of Viscofan will allow us to offer customers in the region a more complete commercial proposition."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.